Pharmacology, Toxicology and Pharmaceutical Science
Polychlorinated Biphenyl
100%
Cytochrome P450
78%
Prasugrel
49%
Clopidogrel
45%
2,3',4',5 Tetrachlorobiphenyl
43%
Guinea Pig
39%
Adverse Event
33%
Hexachlorobiphenyl
31%
Cytochrome P450 1A1
24%
Mouse
23%
Coronary Artery Disease
22%
Cytochrome P450 3A5
22%
CYP3A4
20%
Renal Cell Carcinoma
19%
Selenium Binding Protein
19%
CYP2A6
19%
Glutathione Peroxidase
19%
Warfarin
19%
Pharmacovigilance
19%
Glucuronosyltransferase
18%
Oxygenase
18%
Cytochrome B5
17%
CYP2C19
16%
Phenobarbital
15%
CYP2D6
14%
Isoenzyme
14%
Hemodialysis
14%
Cytochrome P450 2B1
13%
Chemotherapy
12%
Cytochrome
12%
Estrone Sulfate
11%
Aromatic Hydrocarbon
11%
Akaike Information Criterion
11%
Diarrhea
11%
CYP1A2
11%
Methylcholanthrene
11%
Antiplatelet
10%
Colitis
10%
Tacrolimus
9%
Asunaprevir
9%
Daclatasvir
9%
Fructose Bisphosphate Aldolase
9%
Very Low Density Lipoprotein
9%
Pembrolizumab
9%
Ipilimumab
9%
Triose
9%
Retrospective Study
9%
Triazolam
9%
Colorectal Cancer
9%
Kidney Failure
9%
Biochemistry, Genetics and Molecular Biology
CYP2A6
69%
Clopidogrel
45%
Platelet Reactivity
45%
Prasugrel
39%
Enzyme
38%
Genetic Polymorphism
36%
Allele
32%
Metabolic Pathway
27%
Messenger RNA
26%
Cytochrome
24%
Hydroxylation
23%
Genotyping
22%
Gene Deletion
21%
Genetic Determinism
20%
P2Y12
19%
CYP3A5
19%
Arachidonic Acid
19%
Microsomal Epoxide Hydrolase
19%
Enzyme Activity
14%
Isozyme
14%
Coumarin
14%
Oxygenase
14%
Epoxidation
13%
Linoleic Acid
13%
Glycerophospholipid
13%
Epoxide Hydrolase
12%
Case-Control Study
12%
Lipid Metabolism
12%
CYP2C19
12%
Cytochrome P450
11%
Guinea Pig
11%
Demethylation
11%
Dextromethorphan
11%
Amino Acids
11%
Copurification
9%
UGT2B7
9%
Genetic Divergence
9%
Triose
9%
CYP3A7
9%
Lipid Composition
9%
Organic Anion-Transporting Polypeptide
9%
Estrone Sulfate
9%
Biotransformation
9%
CYP3A4
9%
Smoking
9%
CYP2D6
9%
Single-Nucleotide Polymorphism
9%
Pharmacogenetics
9%
UGT1A9
9%
UGT1A6
9%
Keyphrases
Coplanar Polychlorinated Biphenyls
39%
Metabolism
39%
Prasugrel
29%
CYP2A6 Gene
29%
Cytochrome P450 (CYP450)
29%
Hydroxylation
29%
Tetrachlorobiphenyl
22%
Cytochrome P450 2D6 (CYP2D6)
22%
CYP2A6
21%
Liver Microsomes
21%
Gene Deletion
21%
Human Liver Microsomes
20%
Genetic Variants
19%
Guinea pig
19%
Hamster
19%
Rat Liver
19%
PCB Toxicity
19%
Genetic Polymorphism
17%
PCB126
15%
Genotype
15%
Cytochrome P450 3A4 (CYP3A4)
14%
Lung Cancer Risk
14%
Coplanar PCBs
14%
Lung Cancer
14%
Aryl Hydrocarbon
13%
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
12%
Polychlorinated Biphenyl 126
12%
CYP3A5
11%
Inhibitory Effect
11%
Phenobarbital
11%
P2Y12 Reaction Unit
11%
Catalytic Activity
11%
Triazolam
10%
CYP2C9
10%
Liver Cytosol
10%
High Platelet Reactivity
9%
Powder Dispensing
9%
Daclatasvir
9%
CYP2B6 Polymorphisms
9%
Metabolic Phenotype
9%
Direct-acting Antivirals
9%
Adrenal Cell
9%
Cadmium Exposure
9%
Idiosyncratic Hepatotoxicity
9%
Cytochrome P450scc
9%
Asunaprevir
9%
D-type
9%
Partial Characterization
9%
UGT2B7
9%
UGT1A9
9%